Peter Pin-Sung Liu Selected Research

Warfarin (Coumadin)

1/2022	Diabetes-Related Complications and Mortality in Patients With Atrial Fibrillation Receiving Different Oral Anticoagulants : A Nationwide Analysis.
1/2021	Fracture Risks in Patients Treated With Different Oral Anticoagulants: A Systematic Review and Meta-Analysis.
1/2021	Risk of developing diabetes in patients with atrial fibrillation taking non-vitamin K antagonist oral anticoagulants or warfarin: A nationwide cohort study.
1/2021	Lower Risk of Dementia in Patients With Atrial Fibrillation Taking Non-Vitamin K Antagonist Oral Anticoagulants: A Nationwide Population-Based Cohort Study.
1/2020	Risk of Osteoporosis in Patients With Atrial Fibrillation Using Non-Vitamin K Antagonist Oral Anticoagulants or Warfarin.
1/2020	Fracture risks among patients with atrial fibrillation receiving different oral anticoagulants: a real-world nationwide cohort study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peter Pin-Sung Liu Research Topics

Disease

5	Atrial Fibrillation 01/2022 - 01/2020
2	Venous Thromboembolism 02/2022 - 03/2020
1	Hyperglycemic Hyperosmolar Nonketotic Coma (Nonketotic Hyperglycemic Coma) 02/2022
1	Diabetes Mellitus 01/2022
1	Diabetes Complications 01/2022
1	Dementia (Dementias) 01/2021
1	Hemorrhage 01/2021
1	Stroke (Strokes) 01/2021
1	Bone Fractures (Bone Fracture) 01/2021
1	Hypothyroidism 03/2020
1	Osteoporosis 01/2020

Drug/Important Bio-Agent (IBA)

6	AnticoagulantsIBA 02/2022 - 01/2020
6	Warfarin (Coumadin)FDA LinkGeneric 01/2022 - 01/2020
5	Vitamin K FDA Link 01/2022 - 01/2020
3	N(4)-oleylcytosine arabinosideIBA 01/2022 - 01/2020
1	Thyroxine (Levothyroxine)FDA LinkGeneric 03/2020
1	apixabanIBA 01/2020
1	Dabigatran FDA Link 01/2020
1	RivaroxabanIBA 01/2020

Therapy/Procedure

1	Therapeutics 03/2020
1	Duration of Therapy 01/2020